We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Stresses Testing of Porcine-Derived Starting Materials to Protect Supply Chain
EMA Stresses Testing of Porcine-Derived Starting Materials to Protect Supply Chain
Drugmakers should test porcine trypsin, a starting material used in biologic drugs, just after it is produced to ensure material from a single infected pig doesn’t enter production batches, the European Medicines Agency says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor